Abbott Laboratories (ABT)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Abbott Laboratories (ABT)
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Key Insights
Critical company metrics and information
Share Price
$114.86Market Cap
$199.22 BillionTotal Outstanding Shares
1.73 Billion SharesTotal Employees
114,000Dividend
$0.55 Per Share QuarterlyIPO Date
April 19, 1949SIC Description
Pharmaceutical PreparationsHomepage
https://www.abbottinvestor.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities, Continuing | $-2.30 Billion |
Net Cash Flow | $837.00 Million |
Net Cash Flow From Financing Activities | $-5.59 Billion |
Net Cash Flow From Operating Activities | $8.73 Billion |
Net Cash Flow From Operating Activities, Continuing | $8.73 Billion |
Net Cash Flow From Investing Activities | $-2.30 Billion |
Net Cash Flow From Financing Activities, Continuing | $-5.59 Billion |
Net Cash Flow, Continuing | $837.00 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Income/Loss From Continuing Operations After Tax | $5.77 Billion |
Cost Of Revenue | $18.32 Billion |
Diluted Average Shares | $1.75 Billion |
Benefits Costs and Expenses | $34.44 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $5.75 Billion |
Operating Expenses | $16.20 Billion |
Preferred Stock Dividends And Other Adjustments | $22.00 Million |
Research and Development | $2.79 Billion |
Revenues | $41.22 Billion |
Diluted Earnings Per Share | $3.29 |
Selling, General, and Administrative Expenses | $11.51 Billion |
Income Tax Expense/Benefit | $1.01 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $22.00 Million |
Basic Average Shares | $1.74 Billion |
Basic Earnings Per Share | $3.30 |
Other Operating Expenses | $1.89 Billion |
Income/Loss From Continuing Operations Before Tax | $6.78 Billion |
Net Income/Loss | $5.77 Billion |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Gross Profit | $22.90 Billion |
Net Income/Loss Attributable To Parent | $5.77 Billion |
Operating Income/Loss | $6.69 Billion |
Costs And Expenses | $34.52 Billion |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Liabilities And Equity | $74.36 Billion |
Assets | $74.36 Billion |
Other Current Liabilities | $13.28 Billion |
Noncurrent Liabilities | $19.43 Billion |
Equity Attributable To Noncontrolling Interest | $232.00 Million |
Other Current Assets | $16.99 Billion |
Noncurrent Assets | $50.55 Billion |
Liabilities | $34.33 Billion |
Equity Attributable To Parent | $39.80 Billion |
Current Assets | $23.80 Billion |
Intangible Assets | $7.35 Billion |
Equity | $40.03 Billion |
Fixed Assets | $10.62 Billion |
Inventory | $6.81 Billion |
Other Non-current Assets | $32.58 Billion |
Current Liabilities | $14.90 Billion |
Wages | $1.62 Billion |
Historical Dividends
Current dividend: $0.55 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Sep 19, 2024 | Nov 15, 2024 | Oct 15, 2024 | $0.55 | Quarterly |
Jun 14, 2024 | Aug 15, 2024 | Jul 15, 2024 | $0.55 | Quarterly |
Feb 16, 2024 | May 15, 2024 | Apr 15, 2024 | $0.55 | Quarterly |
Dec 15, 2023 | Feb 15, 2024 | Jan 12, 2024 | $0.55 | Quarterly |
Sep 21, 2023 | Nov 15, 2023 | Oct 13, 2023 | $0.51 | Quarterly |
Jun 9, 2023 | Aug 15, 2023 | Jul 14, 2023 | $0.51 | Quarterly |
Feb 17, 2023 | May 15, 2023 | Apr 14, 2023 | $0.51 | Quarterly |
Dec 9, 2022 | Feb 15, 2023 | Jan 13, 2023 | $0.51 | Quarterly |
Sep 15, 2022 | Nov 15, 2022 | Oct 14, 2022 | $0.47 | Quarterly |
Jun 10, 2022 | Aug 15, 2022 | Jul 15, 2022 | $0.47 | Quarterly |
Feb 18, 2022 | May 16, 2022 | Apr 15, 2022 | $0.47 | Quarterly |
Dec 10, 2021 | Feb 15, 2022 | Jan 14, 2022 | $0.47 | Quarterly |
Sep 15, 2021 | Nov 15, 2021 | Oct 15, 2021 | $0.45 | Quarterly |
Jun 11, 2021 | Aug 16, 2021 | Jul 15, 2021 | $0.45 | Quarterly |
Feb 19, 2021 | May 17, 2021 | Apr 15, 2021 | $0.45 | Quarterly |
Dec 11, 2020 | Feb 16, 2021 | Jan 15, 2021 | $0.45 | Quarterly |
Sep 17, 2020 | Nov 16, 2020 | Oct 15, 2020 | $0.36 | Quarterly |
Jun 12, 2020 | Aug 17, 2020 | Jul 15, 2020 | $0.36 | Quarterly |
Feb 21, 2020 | May 15, 2020 | Apr 15, 2020 | $0.36 | Quarterly |
Dec 13, 2019 | Feb 14, 2020 | Jan 15, 2020 | $0.36 | Quarterly |
Sep 12, 2019 | Nov 15, 2019 | Oct 15, 2019 | $0.32 | Quarterly |
Jun 14, 2019 | Aug 15, 2019 | Jul 15, 2019 | $0.32 | Quarterly |
Feb 22, 2019 | May 15, 2019 | Apr 15, 2019 | $0.32 | Quarterly |
Dec 14, 2018 | Feb 15, 2019 | Jan 15, 2019 | $0.32 | Quarterly |
Sep 13, 2018 | Nov 15, 2018 | Oct 15, 2018 | $0.28 | Quarterly |
Jun 8, 2018 | Aug 15, 2018 | Jul 13, 2018 | $0.28 | Quarterly |
Feb 16, 2018 | May 15, 2018 | Apr 13, 2018 | $0.28 | Quarterly |
Dec 15, 2017 | Feb 15, 2018 | Jan 12, 2018 | $0.28 | Quarterly |
Sep 14, 2017 | Nov 15, 2017 | Oct 13, 2017 | $0.265 | Quarterly |
Jun 9, 2017 | Aug 15, 2017 | Jul 14, 2017 | $0.265 | Quarterly |
Feb 17, 2017 | May 15, 2017 | Apr 14, 2017 | $0.265 | Quarterly |
Dec 9, 2016 | Feb 15, 2017 | Jan 13, 2017 | $0.265 | Quarterly |
Sep 15, 2016 | Nov 15, 2016 | Oct 14, 2016 | $0.26 | Quarterly |
Jun 10, 2016 | Aug 15, 2016 | Jul 15, 2016 | $0.26 | Quarterly |
Feb 19, 2016 | May 16, 2016 | Apr 15, 2016 | $0.26 | Quarterly |
Dec 11, 2015 | Feb 16, 2016 | Jan 15, 2016 | $0.26 | Quarterly |
Sep 17, 2015 | Nov 15, 2015 | Oct 15, 2015 | $0.24 | Quarterly |
Jun 12, 2015 | Aug 15, 2015 | Jul 15, 2015 | $0.24 | Quarterly |
Feb 20, 2015 | May 15, 2015 | Apr 15, 2015 | $0.24 | Quarterly |
Dec 12, 2014 | Feb 13, 2015 | Jan 15, 2015 | $0.24 | Quarterly |
Sep 11, 2014 | Nov 15, 2014 | Oct 15, 2014 | $0.22 | Quarterly |
Jun 13, 2014 | Aug 15, 2014 | Jul 15, 2014 | $0.22 | Quarterly |
Feb 21, 2014 | May 15, 2014 | Apr 15, 2014 | $0.22 | Quarterly |
Oct 16, 2013 | Feb 15, 2014 | Jan 15, 2014 | $0.22 | Quarterly |
Sep 12, 2013 | Nov 15, 2013 | Oct 15, 2013 | $0.14 | Quarterly |
Jun 14, 2013 | Aug 15, 2013 | Jul 15, 2013 | $0.14 | Quarterly |
Feb 15, 2013 | May 15, 2013 | Apr 15, 2013 | $0.14 | Quarterly |
Dec 14, 2012 | Feb 15, 2013 | Jan 15, 2013 | $0.14 | Quarterly |
Sep 13, 2012 | Nov 15, 2012 | Oct 15, 2012 | $0.51 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Abbott Laboratories (ABT)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.